Sun Mar 1 20:28:20 SGT 2015  
SINGAPORE
GENITAL™
    Genital warts treatment, Singapore (SG)
HIV STD TESTING SINGAPORE™
HIV PEP: Stop HIV within 72 hours of sex HIV Test: 20 min result, 28 days after sex STD Testing: Full & comprehensive

Genital warts treatment, Singapore (SG) | HIV STD TESTING SINGAPORE™

Summary

Genital warts treatment, Singapore (SG) | HIV STD TESTING SINGAPORE™ @singaporegenital_com: Genital warts (condyloma, condylomata acuminata, venereal wart, anal wart, anogenital wart, "cauliflower" sex disease) screening/diagnosis, testing/check treatment/removal/cure, Singapore. Private and confidential service. Definitions, references, and latest news.

Description

Genital warts: penile warts / vaginal warts / anal warts / anogenital warts / venereal warts / condyloma / condylomata acuminata / "cauliflower" sex disease.

References

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Genital warts treatment, Singapore (SG)
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception (females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing.
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception (females only)
2 weeks HIV DNA PCR test
1 month 20 minute HIV rapid test - SD Bioline HIV Ag/Ab Combo:
- Fingerprick blood sampling.
3 months 20 minute HIV rapid test - OraQuick®:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

References


Latest News

Human Papillomavirus Vaccination: A Preventative Health Interest for Plastic Surgeons
Sat, 28 Feb 2015 09:22:35 +0100 | Plastic and Reconstructive Surgery
No abstract available (Source: Plastic and Reconstructive Surgery)

The pathology of HPV-related head and neck Cancer: Implications for the diagnostic pathologist
Sat, 28 Feb 2015 00:00:00 +0100 | Seminars in Diagnostic Pathology
A subset of head and neck squamous cell carcinoma are caused by the human papillomavirus (HPV). This HPV-related form of head and neck squamous cell carcinoma (HPV-HNSCC) has captured the attention of the oncology community for its rising incidence, its link to non-traditional risk factors, and its divergent clinical behavior. To diagnose this special form of head and neck squamous cell carcinoma is to provide important prognostic information and, in some instances, redirect clinical therapy. The diagnosis of HPV-HNSCC is aided by a strong appreciation for its characteristic microscopic findings and by an awareness of aberrant features that set apart a growing list of HPV-HNSCC morphologic variants. (Source: Seminars in Diagnostic Pathology)

Predictors of Human Papillomavirus Awareness and Knowledge in 2013 Gaps and Opportunities for Targeted Communication Strategies
Sat, 28 Feb 2015 00:00:00 +0100 | American Journal of Preventive Medicine
Conclusions Although awareness and knowledge of HPV is increasing, there are opportunities to target communication with populations for whom knowledge gaps currently exist, in order to promote dialogue about the vaccine among patients and their providers. (Source: American Journal of Preventive Medicine)

A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer
Fri, 27 Feb 2015 00:00:00 +0100 | Annals of Oncology
Conclusion

Development of anti-E6 pegylated lipoplexes for mucosal application in the context of cervical preneoplastic lesions
Fri, 27 Feb 2015 00:00:00 +0100 | International Journal of Pharmaceutics
In conclusion, pegylated anti-E6 lipoplexes have demonstrated their efficiency to cross the cellular membrane and to release siRNA into the cytoplasm confirmed by final p53 protein production. Graphical abstract (Source: International Journal of Pharmaceutics)

Merck’s 9-Valent HPV Vaccine, GARDASIL®9, Recommended by CDC’s Advisory Committee on Immunization Practices for Females Aged 9-26 and Males Aged 9-21
Thu, 26 Feb 2015 20:18:00 +0100 | Merck.com - Corporate News
Dateline City:

HPV in oropharyngeal cancer: the basics to know in clinical practice.
Thu, 26 Feb 2015 13:35:19 +0100 | Acta Otorhinolaryngologica Italica
Authors: Elrefaey S, Massaro MA, Chiocca S, Chiesa F, Ansarin M

A prospective study of positron emission tomography for evaluation of neck node response 6 weeks after radiotherapy in patients with head and neck squamous cell carcinoma
Thu, 26 Feb 2015 13:26:12 +0100 | Head and Neck
Conclusion:

'Game changer' HIV drug cuts infection risk by 86%
Wed, 25 Feb 2015 13:00:00 +0100 | NHS News Feed
Conclusion

Oncogenic human papillomavirus is not helpful for cytology screening of the precursor lesions of anal cancers in Taiwanese men who are infected with human immunodeficiency virus
Wed, 25 Feb 2015 00:00:00 +0100 | International Journal of Clinical Oncology
Conclusions